Adamax is a synthetic, modified nootropic peptide and a designer analog of Semax
Adamax is a synthetic nootropic peptide derivative. It is an advanced analogue of Semax that combines an N-terminal acetyl group with the C-terminal adamantane modification of P21. These structural enhancements significantly increase its bioactive stability and ability to cross the blood-brain barrier.
NZ$110.00 — in stock
Certificate of Analysis for Adamax · All products
Supplied for laboratory and analytical research use only. Not for human or veterinary use. See our research compliance statement.